knowledge landing page image

Procedural fairness in adjudication?

Biosimilar Use In Australia: A Status Update

Despite Australia’s relatively pro-biosimilar regulatory framework, the uptake of biosimilars in Australia continues to lag behind that observed in Europe and the USA.

30 July 2019
Categories: 

Deal Wrap: Brookfield acquisition of Healthscope

KWM advised Brookfield Business Partners on its proposal to acquire Healthscope. We discussed the innovative aspects of the deal with partners David Eliakim and Yuen-Yee Cho.

17 April 2019

Global moves to reduce the future cost of publicly funded medicines

In order to minimise pressure on health spending, regulators around the world are increasingly looking to promote the availability of ‘biosimilars’ - biological products that are highly similar...

05 October 2018
Categories: 

All eyes on payroll tax as optometrists win appeal in Commissioner of State Revenue v The Optical Superstore Pty Ltd [2018] VSC 524

On 21 September 2018, the Victorian Supreme Court dismissed an appeal by the Commissioner of State Revenue (Commissioner) in Commissioner of State Revenue v The Optical Superstore Pty...

28 September 2018

Morrison’s Christmas promise: Indonesia-Australia free trade agreement

Australia’s new Prime Minister, Scott Morrison has promised the long awaited Indonesia-Australia free trade agreement by Christmas. The announcement is a good news story for international trade...

05 September 2018

IP Australia releases proposed changes to Australia’s patent legislation

IP Australia has released an exposure draft for the proposed Intellectual Property Laws Amendment Bill which proposes several key changes to Australia’s patent laws

31 July 2018
Categories: 

Critical infrastructure: are you ready to report?

Starting on 11 July 2018, owners and operators of Australia’s critical infrastructure assets have 6 months to report current ownership and operating details.

11 July 2018

The final word and ‘smoking gun’ documents - ACCC v Pfizer

Federal Court of Australia dismisses ACCC appeal, finding Pfizer had not misused its substantial market power for an anti-competitive purpose, and had not engaged in exclusive dealing conduct....

05 June 2018

Biotech Insights: 2018 industry snapshot and key trends

Healthcare, medical technology and pharmaceutical innovation continue to be major areas of investment from a broad spectrum of local and off-shore funding bodies.

01 June 2018
Categories: 

Fast drugs, new drugs: new opportunities in the healthcare industry in Australia and China

Chinese and Australian businesses looking for overseas opportunities to expand in the healthcare industry should be aware of important regulatory changes.

27 April 2018

Australian Open Banking Review Released

It provides advice on the design and implementation of Australia’s Open Banking system and is the first stage in a broader consumer data right.

09 February 2018
Categories: 

Deal Wrap: The Ansell Acquisition

KWM acted as global counsel for Humanwell Healthcare (Group) Co., Ltd and CITIC Capital on their US$600 million acquisition of ASX-listed Ansell Limited’s sexual wellness business.

05 December 2017

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.